Forte Biosciences Relocates Principal Executive Offices
Ticker: FBRX · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1419041
Sentiment: neutral
Topics: corporate-event, address-change
TL;DR
Forte Biosciences moved its main office to Dallas, TX, effective April 18, 2025.
AI Summary
On April 18, 2025, Forte Biosciences, Inc. filed an 8-K report. The filing indicates that the company's principal executive offices are now located at 3060 Pegasus Park Drive, Building 6, Dallas, Texas, 75247. This change in address was effective as of April 18, 2025.
Why It Matters
A change in principal executive offices can signal operational shifts or strategic realignments within a company.
Risk Assessment
Risk Level: low — This filing solely reports a change of address for the company's principal executive offices, which is a routine administrative event.
Key Players & Entities
- Forte Biosciences, Inc. (company) — Registrant
- 3060 Pegasus Park Drive, Building 6, Dallas, Texas, 75247 (location) — New Principal Executive Offices
- April 18, 2025 (date) — Effective Date of Address Change
FAQ
What is the new address for Forte Biosciences, Inc.'s principal executive offices?
The new address for Forte Biosciences, Inc.'s principal executive offices is 3060 Pegasus Park Drive, Building 6, Dallas, Texas, 75247.
When did this change of address become effective?
The change of address became effective on April 18, 2025.
What was the previous location of Forte Biosciences, Inc.'s principal executive offices?
The filing does not explicitly state the previous address, only that the new address is effective as of April 18, 2025.
Is this change related to a merger or acquisition?
The filing does not indicate that this change of address is related to a merger or acquisition; it is reported under 'Other Events'.
What is the SIC code for Forte Biosciences, Inc.?
The Standard Industrial Classification (SIC) code for Forte Biosciences, Inc. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding Forte Biosciences, Inc. (FBRX).